Loading clinical trials...
Loading clinical trials...
Data of 100 patients with locally advanced pancreatic cancer who received stereotactic radiotherapy or ct-guided radioactive 125I seed implantation in the multicenter of the research group from July 2...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Peking University Third Hospital
Collaborators
NCT06160323 · Pancreatic Cancer Non-resectable, Tumor Pancreas, and more
NCT07339774 · Radiotherapy-induced Oral Mucositis
NCT07138755 · NSCLC, Sintilimab, and more
NCT07426094 · Prostate Cancer, Brachytherapy, and more
NCT07332000 · Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
Peking University Third Hospital
Beijing, Beijing Municipality
The fifth medical center of PLA general hospital
Beijing, Beijing Municipality
Guangxi Ruikang Hospital
Nanning, Guangxi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions